Navigation Links
Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use

PRINCETON JUNCTION, N.J., May 30 /PRNewswire/ -- Lutronic, Inc., one of the world's leading developers and manufacturers of medical laser systems, announced today that its MOSAIC eCO2 system, the next generation in fractional resurfacing lasers combining fractional technology with the deep ablative features of a CO2 laser, is in its late stages of FDA review and clearance.

With intuitive touch-screen software, the powerful MOSAIC eCO2 features a contoured scanner hand piece with adjustable controls, enabling the practitioner to select various scanning patterns with different shapes and sizes. Unique patented intuitive software allows rapid selections between a continuous pulse, a randomized or sequential beam pattern, as well as penetrating or thermal type tip for patient-specific requirements and customized clinical results. Built-in "smart" fail-safes include sensor technology such as controlled chaos scanning technology (CCST) that minimizes double passing over previously treated skin as well as a hand piece / system interface that prevents the laser from firing unless the hand piece tip is in contact with the skin. In specific indications, the skin contact activated "repeat pulse" feature can be disabled converting the system to a standard "foot pedal" control device. Also featured is an energy-efficient, self-contained slim-line console with a maintenance-free articulated arm delivery system and convenient foot switch.

"The MOSAIC eCO2 is perhaps the most innovative and versatile multi-functional fractional CO2 laser system designed through not only extensive R&D, but doctor input and patient comfort optimization models as well," said Jhung-Won Hwang, Ph.D., Senior Director of Regulatory Affairs, Lutronic, Inc. "And, with our contemporary signature design, MOSAIC eCO2 is the easiest, most sophisticated, and highest quality laser system available today, delivering precision where it counts -- to the patient. Less pain, shorter downtime, and rapid recovery are the cornerstones to this vitally important addition to the Lutronic family of medical laser products."

MOSAIC eCO2 is designed to address a broad scope of clinical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery. A wide range of conditions may be treated with the highest degree of efficacy such as total skin resurfacing, treatment of fine wrinkles, rhytids, acne scars, surgical scars, and uneven pigmentation, such as lentigines and dyschromia.

The MOSAIC eCO2 Laser System utilizes a CO2 tube to generate a laser beam with a wavelength of 10.6 um. Taken together with the unique scanner hand piece, the physician can optimize the effect for different applications by controlling the power of the laser pulse and using a different scan pattern.

"The main differentiating feature of the MOSAIC eCO2 system is the 'freedom' it brings to the practitioner as well as to the patient: freedom from inferior fractional laser systems; freedom from painful treatments and questionable results; freedom to self-select depth and density of treatment; and freedom to select Static and Dynamic modes to deliver the very best results possible.

"The ability to combine two operation modes in one delivery system is particularly important when comparing MOSAIC eCO2 to other fractional CO2 lasers," continued Dr. Hwang. "Static mode offers deeper penetration and greater patient comfort, and Dynamic mode is ideal for larger area blending and smoothing. The laser works exceptionally well in medical applications because 10.6 um is near the peak of tissue water absorption, and when water in the tissue absorbs the laser energy, it heats up. This heating causes instantaneous vaporization of the target tissue. This smart system is yet another example of Lutronic's tireless efforts as the vanguard in breakthrough aesthetic and clinical laser technology."

About Lutronic

Lutronic is one of the world's leading developers and manufacturers of medical laser systems serving the clinical dermatological and aesthetic communities. With over a decade of award-winning technology design that includes its Spectra line of products and its unparalleled MOSAIC Systems, the company is committed to delivering innovative, highly effective, and painless laser solutions. In addition, Lutronic, Inc. offers an impressive service department featuring experienced laser engineers who provide the highest level of service and support to physicians across the US. Manufacturing medical laser systems for markets in Europe and Asia, parent Lutronic Co. Ltd. is based in Seoul, South Korea and delivers products to over 40 countries. To learn more about the MOSAIC eCO2 Laser System, please visit


Ken Reich

Director, Marketing & Public Relations

Lutronic, Inc.

Phone: 609 275-1565 x302 or 888 588-7644

Fax: 609 275-3800


This release was issued through eReleases (TM). For more information, visit

SOURCE Lutronic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
2. Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions
3. Elbit Imaging Ltd. Announces First Quarter Results for 2008
4. ASTRO announces 2008 gold medalists
5. Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008
6. Darwin Announces Creation of New Health Care and Errors and Omissions Divisions
7. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
8. Ekahau Announces Compatibility With 802.11n
9. Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1
10. DRAXIS Announces Completion of Sale to Jubilant
11. WellPoint Announces Realignment of Operations, Technology and Government Services Unit
Post Your Comments:
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology: